A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence
Latest Information Update: 06 Nov 2021
At a glance
- Drugs NS 2359 (Primary)
- Indications Cocaine-related disorders
- Focus Proof of concept; Therapeutic Use
- 06 Oct 2020 Status changed from recruiting to completed.
- 10 Sep 2019 Planned End Date changed from 1 Jul 2019 to 1 Jul 2021.
- 10 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2021.